Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

INDUSTRIAL HEALTH is a premier journal dedicated to the dissemination of innovative research in the fields of public health, environmental and occupational health, as well as toxicology and mutagenesis. Published by the National Institute of Occupational Safety and Health in Japan, the journal has been a critical resource for over six decades, covering essential topics from 1963 to the present day. With an impressive placement in the second quartile (Q2) of the Public Health, Environmental and Occupational Health category and a third quartile (Q3) in Health, Toxicology, and Mutagenesis, it is recognized for its significant contribution to advancing knowledge and improving practices within the industry. While not an open-access journal, INDUSTRIAL HEALTH offers researchers and students access to a wealth of knowledge through its rich archive of articles, fostering a deeper understanding of health and safety challenges in industrial settings. The journal’s dedication to high-quality research and its strategic role in promoting occupational safety make it an invaluable asset for professionals seeking to enhance health standards and safety protocols worldwide.

The International Journal of Toxicology, published by SAGE Publications Inc, serves as a cornerstone of scholarly research in the field of toxicology, with an established history dating back to 1982. This esteemed journal, ISSN 1091-5818 and E-ISSN 1092-874X, functions within the Q3 quartile in Toxicology, ranking 94 out of 133 in the Pharmacology, Toxicology and Pharmaceutics category per Scopus metrics, reflecting its commitment to advancing scientific understanding in this critical area. The journal not only aims to disseminate high-quality research but also encourages open access to vital studies, thus fostering collaboration and innovation among researchers, professionals, and students alike. With a focus on various aspects of toxicology, including but not limited to environmental, clinical, and molecular toxicology, the International Journal of Toxicology is dedicated to bridging gaps in toxicity research and promoting safe practices across numerous disciplines. As it converges towards 2024, the journal continues to play a vital role in shaping the discourse surrounding the implications of exposure to toxic substances in human health and the environment.

ARCHIVES OF TOXICOLOGY is a prestigious journal published by Springer Heidelberg, dedicated to advancing research in the field of toxicology and related disciplines. With a distinguished history dating back to 1930, this journal has continuously provided vital insights and groundbreaking studies, making it a cornerstone in the areas of health, toxicology, and medicine. Recognized for its high impact, it occupies a top-ranking position in Scopus, with remarkable quartile placements in 2023, categorizing it as Q1 in Health, Toxicology and Mutagenesis, and Q1 in Medicine (Miscellaneous). The journal highlights critical research and innovative methodologies, appealing to a diverse audience of researchers, professionals, and students committed to understanding the complexities of toxic substances and their implications for public health and environmental safety. The journal does not currently offer open access, allowing for a more traditional but rigorous peer-review process that ensures the quality and integrity of every published article. Join the global discourse in toxicological science with ARCHIVES OF TOXICOLOGY, where every contribution furthers the understanding of safety and toxicity in our world.

Journal of Hazardous Materials Letters, published by ELSEVIER, is a premier open access journal that has rapidly gained prominence in the fields of Environmental Chemistry, Environmental Engineering, Health, Toxicology and Mutagenesis, Pollution, and Waste Management and Disposal since its inception in 2020. With an impressive categorization in the top quartile (Q1) across all its relevant disciplines in 2023, this journal ranks favorably within the Scopus database, positioning itself in the upper echelons of Environmental Science—ranked 23rd in Environmental Engineering and 19th in Health, Toxicology and Mutagenesis among its peers. It serves as a vital platform for the dissemination of high-quality research focused on addressing hazardous materials and their impacts on health and the environment. The journal's commitment to open access facilitates immediate and broad dissemination of research findings, ensuring that essential knowledge reaches a global audience of researchers, professionals, and students eager to advance the field. With its ongoing convergence into 2024, the Journal of Hazardous Materials Letters continues to drive innovation and influence practice in managing hazardous materials for a sustainable future.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

HUMAN MOLECULAR GENETICS, published by Oxford University Press, is a premier journal in the field of genetics, with an established reputation since its inception in 1992. With an impressive Q1 ranking in various categories, including Genetics, Clinical Genetics, and Molecular Biology, this journal engages a diverse readership by reporting significant advances in our understanding of the genetic basis of human health and disease. The journal has achieved notable rankings within Scopus, particularly in Clinical Genetics, making it a key resource for professionals and researchers aiming to stay at the forefront of genetic research. Although it operates under a traditional access model, it remains committed to disseminating high-quality research that informs clinical practice and enhances knowledge in the genetic field. The journal's impact factor signifies its crucial role in shaping contemporary genetic research and its application in medicine. As the field continues to evolve, HUMAN MOLECULAR GENETICS serves not only as an academic repository but also as a vital platform for innovation and discussion among students, researchers, and clinicians.

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Journal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.